根据ESI于2024年5月发布的数据，我校高被引论文（Highly Cited Papers）440篇，热点论文（Hot Papers）15篇，见附件：2024年5月南方医科大学高被引论文及热点论文简表。详情如下。
从学科角度看，在431篇高被引论文中，临床医学最多（216篇），占比50.12%，分子生物学与遗传学38篇（8.82%）紧跟其后。
|
序号 |
高被引论文 Research Field |
2024.05 |
2024.03 |
||
|
论文数 |
占比 |
论文数 |
占比 |
||
|
1 |
CLINICAL MEDICINE |
218 |
49.55% |
216 |
50.12% |
|
2 |
MOLECULAR BIOLOGY & GENETICS |
39 |
8.86% |
38 |
8.82% |
|
3 |
BIOLOGY & BIOCHEMISTRY |
32 |
7.27% |
32 |
7.42% |
|
4 |
PHARMACOLOGY & TOXICOLOGY |
33 |
7.50% |
32 |
7.42% |
|
5 |
MATERIALS SCIENCE |
26 |
5.91% |
28 |
6.50% |
|
6 |
NEUROSCIENCE & BEHAVIOR |
18 |
4.09% |
17 |
3.94% |
|
7 |
ENGINEERING |
5 |
1.14% |
4 |
0.93% |
|
8 |
MICROBIOLOGY |
9 |
2.05% |
7 |
1.62% |
|
9 |
CHEMISTRY |
5 |
1.14% |
4 |
0.93% |
|
10 |
PHYSICS |
10 |
2.27% |
10 |
2.32% |
|
11 |
PSYCHIATRY/PSYCHOLOGY |
10 |
2.27% |
10 |
2.32% |
|
12 |
IMMUNOLOGY |
8 |
1.82% |
8 |
1.86% |
|
13 |
SOCIAL SCIENCES, GENERAL |
5 |
1.14% |
5 |
1.16% |
|
14 |
COMPUTER SCIENCE |
12 |
2.73% |
11 |
2.55% |
|
15 |
GEOSCIENCES |
0 |
0 |
1 |
0.23% |
|
16 |
AGRICULTURAL SCIENCES |
5 |
1.14% |
4 |
0.93% |
|
17 |
MULTIDISCIPLINARY |
1 |
0.23% |
1 |
0.23% |
|
18 |
ENVIRONMENT/ECOLOGY |
3 |
0.68% |
3 |
0.70% |
|
19 |
MATHEMATICS |
1 |
0.23% |
0 |
0 |
|
20 |
合计 |
440 |
100.00% |
431 |
100.00% |
|
序号 |
2024年5月我校15篇热点论文 标题 |
来源期刊 |
DOI |
Research Field |
Times Cited |
|
1 |
SPATIOTEMPORAL TRANSCRIPTOMIC ATLAS OF MOUSE ORGANOGENESIS USING DNA NANOBALL-PATTERNED ARRAYS |
CELL 185 (10): 1777-+ MAY 12 2022 |
10.1016/j.cell.2022.04.003 |
MOLECULAR BIOLOGY & GENETICS |
251 |
|
2 |
TRIAL OF ENDOVASCULAR THERAPY FOR ACUTE ISCHEMIC STROKE WITH LARGE INFARCT |
NEW ENGLAND JOURNAL OF MEDICINE 388 (14): 1272-1283 APR 6 2023 |
10.1056/NEJMoa2213379 |
CLINICAL MEDICINE |
148 |
|
3 |
EXOSOMES-LOADED ELECTROCONDUCTIVE HYDROGEL SYNERGISTICALLY PROMOTES TISSUE REPAIR AFTER SPINAL CORD INJURY VIA IMMUNOREGULATION AND ENHANCEMENT OF MYELINATED AXON GROWTH |
ADVANCED SCIENCE 9 (13): - MAY 2022 |
10.1002/advs.202105586 |
PHYSICS |
118 |
|
4 |
NETWORK PHARMACOLOGY PREDICTION AND MOLECULAR DOCKING-BASED STRATEGY TO EXPLORE THE POTENTIAL MECHANISM OF HUANGLIAN JIEDU DECOCTION AGAINST SEPSIS |
COMPUTERS IN BIOLOGY AND MEDICINE 144: - MAY 2022 |
10.1016/j.compbiomed.2022.105389 |
COMPUTER SCIENCE |
109 |
|
5 |
ESTIMATED BURDEN OF STROKE IN CHINA IN 2020 |
JAMA NETWORK OPEN 6 (3): - MAR 2023 |
10.1001/jamanetworkopen.2023.1455 |
CLINICAL MEDICINE |
91 |
|
6 |
ASSOCIATION BETWEEN GUT MICROBIOTA AND PREECLAMPSIA-ECLAMPSIA: A TWO-SAMPLE MENDELIAN RANDOMIZATION STUDY |
BMC MEDICINE 20 (1): - NOV 15 2022 |
10.1186/s12916-022-02657-x |
CLINICAL MEDICINE |
87 |
|
7 |
IMMUNE CHECKPOINT MODULATORS IN CANCER IMMUNOTHERAPY: RECENT ADVANCES AND EMERGING CONCEPTS |
JOURNAL OF HEMATOLOGY & ONCOLOGY 15 (1): - AUG 17 2022 |
10.1186/s13045-022-01325-0 |
CLINICAL MEDICINE |
86 |
|
8 |
EXOSOMES DECORATED WITH A RECOMBINANT SARS-COV-2 RECEPTOR-BINDING DOMAIN AS AN INHALABLE COVID-19 VACCINE |
NATURE BIOMEDICAL ENGINEERING 6 (7): - JUL 2022 |
10.1038/s41551-022-00902-5 |
BIOLOGY & BIOCHEMISTRY |
80 |
|
9 |
OVERALL SURVIVAL WITH OSIMERTINIB IN RESECTED <I>EGFR</I>-MUTATED NSCLC |
NEW ENGLAND JOURNAL OF MEDICINE 389 (2): 137-147 JUL 13 2023 |
10.1056/NEJMoa2304594 |
CLINICAL MEDICINE |
62 |
|
10 |
REPRESSION OF THE ANTIPORTER SLC7A11/GLUTATHIONE/GLUTATHIONE PEROXIDASE 4 AXIS DRIVES FERROPTOSIS OF VASCULAR SMOOTH MUSCLE CELLS TO FACILITATE VASCULAR CALCIFICATION |
KIDNEY INTERNATIONAL 102 (6): 1259-1275 DEC 2022 |
10.1016/j.kint.2022.07.034 |
CLINICAL MEDICINE |
58 |
|
11 |
ADJUVANT OSIMERTINIB FOR RESECTED EGFR-MUTATED STAGE IB-IIIA NON-SMALL-CELL LUNG CANCER: UPDATED RESULTS FROM THE PHASE III RANDOMIZED ADAURA TRIAL |
JOURNAL OF CLINICAL ONCOLOGY 41 (10): 1830-+ APR 1 2023 |
10.1200/JCO.22.02186 |
CLINICAL MEDICINE |
57 |
|
12 |
CAMRELIZUMAB PLUS RIVOCERANIB VERSUS SORAFENIB AS FIRST-LINE THERAPY FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA (CARES-310): A RANDOMISED, OPEN-LABEL, INTERNATIONAL PHASE 3 STUDY |
LANCET 402 (10408): 1133-1146 SEP 30 2023 |
10.1016/S0140-6736(23)00961-3 |
CLINICAL MEDICINE |
51 |
|
13 |
AGGREGATION-INDUCED EMISSION (AIE), LIFE AND HEALTH |
ACS NANO 17 (15): 14347-14405 JUL 24 2023 |
10.1021/acsnano.3c03925 |
MATERIALS SCIENCE |
29 |
|
14 |
EXOSOMAL LOC85009 INHIBITS DOCETAXEL RESISTANCE IN LUNG ADENOCARCINOMA THROUGH REGULATING ATG5-INDUCED AUTOPHAGY |
DRUG RESISTANCE UPDATES 67: - MAR 2023 |
10.1016/j.drup.2022.100915 |
PHARMACOLOGY & TOXICOLOGY |
22 |
|
15 |
TISLELIZUMAB VS SORAFENIB AS FIRST-LINE TREATMENT FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA A PHASE 3 RANDOMIZED CLINICAL TRIAL |
JAMA ONCOLOGY 9 (12): 1651-1659 DEC 2023 |
10.1001/jamaoncol.2023.4003 |
CLINICAL MEDICINE |
10 |
